The aims and objectives of the Committee on Evidence-based Laboratory Medicine are to:
1. Promote the understanding and the methodology of EBLM by educating laboratory professionals about
2. Support rational laboratory use by implementation of results from EBLM into daily practice. This can be achieved by methodological research, international surveys and by educating laboratory professionals in the following topics:
3. Promote the international dissemination of and collaboration in EBLM
Terms of members are indicated in the C-EBLM page of the IFCC website
Members are indicated in the C-EBLM page of the IFCC website
|Name||Full Member Society|
|A. Fares Taie||Confederacion Unificada Bioquimica de la Republica Argentina (CUBRA)|
|D. Rogic||Croatian Society for Medical Biochemistry (HDMB)|
|R. Lange||German Society of Clinical Chemistry and Laboratory Medicine|
|V. Takhur||Association of Clinical Biochemists of India (ACBI)|
|Y. Dickstein||Israel Society for Clinical Laboratory Science|
|P. Pezzati||Italian Society of Clinical Chemistry and Clinical Molecular Biology (SIBioC)|
|M. Murakami||Japan Society of Clinical Chemistry (JSCC)|
|V. Banys||Lithuanian Society of Laboratory Medicine|
|H. Isah||Association of Clinical Chemists Nigeria (ACCN)|
|H.K.Ayesha||Pakistan Society of Chemical Patholosgists|
|G.J. Sousa||Portugese Society of Clinical Chemistry (SPQC)|
|N. Majkic Singh||Society of Medical Biochemists of Serbia (SMBS)|
|J. Vavrik||Slovak Society of Clinical Biochemistry (SSKB)|
|X. Filella||Sociedad Española de Medicina de Laboratorio (SEQCML)|
|C. Queijo||Association Bioquimica Uruguaya (ABU)|
|S. Kahn||American Association for Clinical Chemistry (AACC)|
|S. Demir||Turkish Biochemical Society (TBS)|
|R.Vinod Mahato||Nepalese Association for Clinical Chemistry (NAAC)|
|R. Schneider||Abbott Laboratories|
|R. Thomae||PHC Europe B.V.|
|K. Olson||Siemens Healthcare Diagnostics|
How to become a member or corresponding member of the committee?
The organisational framework of IFCC Divisions and Committees can be viewed in the IFCC handbook.
To become a member or corresponding member of the committee, candidates should submit a formal application with a brief plan (max. 250 words) of their contribution to the aims and objectives of the C-EBLM. A short CV (max. 1 page), underlining the qualifications and prior experience or publications in evidence-based (laboratory) medicine, should also be attached. Members and corresponding members should be officially recommended by their National Society and a formal letter of support should accompany the application. Applications will be reviewed and officially endorsed by the Executive Committee of the Education and Management Division (EC-EMD) of IFCC, and the EMD and/or C-EBLM chair will officially inform successful candidates.
should be addressed to the chairperson of the committee
Members should have prior knowledge and experience in EBM or EBLM. Members are expected to participate actively in the activities of the Committee. Membership involves approximately 2-3 days commitment per month. Failure to contribute significantly may result in the loss of membership.
Corresponding members: The committee is open to corresponding membership from member organisations of IFCC. One corresponding member should represent the IFCC member state in the committee. Applications are welcome from countries which are not yet represented in the committee (see membership area). Corresponding members should be interested in evidence based medicine. Prior experience in evidence-based methodology is an advantage. Candidates should be active in EBLM or related fields in their own countries. Corresponding members are expected to form a link and a communication channel between the C-EBLM and the relevant national professional organisation(s).
Corresponding membership involves approximately one day commitment per month.
Consultants are either former members of C-EBLM or external experts who support the activities of the committee and advise on specific matters, at the request of the chairperson of the committee.